Bachem
Compare Bachem…Swiss pure-play peptide CDMO; largest globally. CHF ~400M capex 2024 to 2025 across Bubendorf, Vista, and Torrance to expand solid-phase peptide synthesis capacity for GLP-1 demand.
SectorsGLP-1
Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
BachemSwiss pure-play peptide CDMO; largest globally. CHF ~400M capex 2024 to 2025 across Bubendorf, Vista, and Torrance to expand solid-phase peptide synthesis capacity for GLP-1 demand.
All metrics are vertically resized to show how they've changed over time. They're not on the same Y-axis. This chart is meant to compare trends, not values.
Values normalized to 0-100 scale for comparison. Hover for actual values.